Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Mar 15, 2023 · 10-Q · 43 days after period end · 0001214659-23-003850
| Metric | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|
| Net Income | -$5.43M | -$2.57M | -$1.12M |
| EPS Diluted | -$0.83 | -$0.03 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Jan 31, 2023 · filed Mar 15, 2023 · 43 d after period end
